Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Receivables - Other (2018 - 2020)

Updated

Korro Bio (KRRO) reported Receivables - Other of $246,000 for Q1 2020, down 69.4% from the prior quarter.

Analysis

Korro Bio (KRRO) Receivables - Other (2018 - 2020) Analysis & Trends

At the end of FY2019, Korro Bio posted Receivables - Other of $805,000, up 400.0% from FY2018.

  • By year, Receivables - Other came in at $161,000 in FY2018.
  • The Q1 2020 figure ranks as the lowest quarterly Receivables - Other since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Korro Bio 281.05 Mn -128.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 246,000.00
Dec 31, 2019 805,000.00
Sep 30, 2019 408,000.00
Dec 31, 2018 161,000.00
API Access

Korro Bio Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=KRRO&period=max&api_key=YOUR_API_KEY